Skip to main content
OpenTrials

Clinical trial condition

Advanced Solid Cancers Refractory to PD-1 and PD-L1 Therapies

Explore clinical trials studying Advanced Solid Cancers Refractory to PD-1 and PD-L1 Therapies. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Advanced Solid Cancers Refractory to PD-1 and PD-L1 Therapies trial results

Completed

AGEN1884, an Anti-CTLA-4 Human Monoclonal Antibody in Participants With Advanced or Refractory Cancer and Who Have Progressed With PD-1/PD-L1 Inhibitor as Their Most Recent Therapy

NCT02694822

Conditions
Advanced Solid Cancers, Advanced Solid Cancers Refractory to PD-1 and PD-L1 Therapies
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • University of Miami Miller School of Medicine Miami, Florida, United States
View Trial Details

Related conditions